The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to ...

Jaguar Jonze will be part of the national team representing Australia at the Freediving World Championship in Cyprus this ...

A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” and 1 day of acute “9 out of 10” left eye pain.She had a medical history of ...

Geraghty was a victim of medical gaslighting — the dismissal or minimization of a patient’s symptoms. The term derives from a ...

Investing in biotechnology stocks is similar to the drug development process itself. That is, investors frequently experience ...

In light of recent federal research funding cuts, the Arthritis Foundation and CARRA each contributed an additional $100,000 to support the grant program this year. Meanwhile, demand for research ...

Cullinan's innovative approach and Zipalertinib's potential approval in 2026 position it as a promising biotech investment.

Last week Tuesday, PureTech had announced that Raju Kucherlapati stepped down immediately as chair and was replaced by Sharon Barber-Lui, who will be interim chair and also lead the process for ...

Memories are a funny thing too. When one tries hard to remember, they somehow recede into the distance. In moments of quiet, ...